Cited by

• A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.

  Longmore J, Berry JL, Szabadi E, Bradshaw CM. Longmore J, et al. Eur J Clin Pharmacol. 1990;39(3):305-9. doi: 10.1007/BF00315118. Eur J Clin Pharmacol. 1990. PMID: 2257872 Clinical Trial.
• Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome.

  Bates AT, Chamberlain S, Champion M, Foley L, Hughes E, Jani B, Mehta H, Smith SE. Bates AT, et al. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):215-7. doi: 10.1136/jnnp.58.2.215. J Neurol Neurosurg Psychiatry. 1995. PMID: 7876854 Free PMC article.
• Interactions of amitriptyline with guanethidine and thymoxamine in the human iris.

  Ghose K, Dobree C, Taylor P, Turner P. Ghose K, et al. Br J Clin Pharmacol. 1974 Dec;1(6):516-7. doi: 10.1111/j.1365-2125.1974.tb01707.x. Br J Clin Pharmacol. 1974. PMID: 22454943 Free PMC article. No abstract available.
• Interactions of monoamine oxidase inhibition and sympathomimetic amines on the human iris.

  Bevan-Jones B, Lind NA. Bevan-Jones B, et al. Br J Pharmacol. 1971 Feb;41(2):428P-429P. Br J Pharmacol. 1971. PMID: 5572317 Free PMC article. No abstract available.
• The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers.

  Szabadi E, Bradshaw CM, Gaszner P. Szabadi E, et al. Psychopharmacology (Berl). 1980;68(2):125-34. doi: 10.1007/BF00432129. Psychopharmacology (Berl). 1980. PMID: 6107945 Clinical Trial.